CM8720s RSV Vaccine
RSV VACCINE STUDY FOR 60-80 YEAR OLDS, REGISTER YOUR INTEREST NOW
ANTICIPATED START DATE – MAY 2021
Respiratory Syncitial Virus (RSV) is a leading cause of severe lower respiratory tract (LRT) disease in elderly populations.
When an adult gets RSV infection, they typically have mild cold-like symptoms. But RSV can sometimes lead to serious conditions such as Pneumonia (infection of the lungs).
- Age: 60-80 year olds
- Sex: Males and females
- BMI: < = 40
- Medication: No inhaled or systemic corticosteroids
- Medical History: Stable chronic disease permitted
- Smoking History: Not exclusionary
- 14-17 visits (depends on cohort) over approx. 1 year
- Approx. $2500 -$3000
How to apply
To register your interest in this trial, please complete this form. A Fusion team member will be in contact to discuss your eligibility shortly.